Factors that associated with TB patient admission rate and TB inpatient service cost: a cross-sectional study in China

Infectious Diseases of Poverty

Hong Wang⁵  Pingbo Wu³  Hui Jiang⁶  Yang Zhou²  Kaori D. Sato¹  Jiaying Chen⁴  Hongyan Hu⁴ 

[1] Duke Global Health Institute, Duke University, Durham, NC, USA;Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China;Hanzhong Center for Disease Control and Prevention, Hanzhong, Shaanxi Province, China;Center for Health Policy Studies, Nanjing Medical University, Hanzhong Road 140, Nanjing, 210029, P. R. China;Bill & Melinda Gates Foundation, Seattle, WA, USA;Zhenjiang Center for Disease Control and Prevention, Zhenjiang, Jiangsu Province, China

关键词: China;    Health care financing;    Service cost;    Admission rate;    Tuberculosis;   

Others  :  1235700
DOI  :  10.1186/s40249-016-0097-x

 received in 2015-09-28, accepted in 2016-01-04,  发布年份 2016

【 摘 要 】

Background

China has recently adopted the “TB designated hospital model” to improve the quality of tuberculosis (TB) treatment and patient management. Considering that inpatient service often results in high patient financial burden, and therefore influences patient adherence to treatment, it is critical to better understand the TB patient admission rate and TB inpatient service cost, as well as their influential factors in this new model.

Methods

Quantitative and qualitative studies were conducted in two cities, Hanzhong in Shaanxi Province and Zhenjiang in Jiangsu Province, in China. Quantitative data were obtained from a sample survey of 533 TB patients and TB inpatient records from 2010–2012 in six county designated hospitals. Qualitative information was obtained through interviews with key stakeholders (40 key informant interviews, 14 focus group discussions) and reviews of health policy documents in study areas. Both univariate and multivariate statistical analyses were applied for the quantitative analysis, and the thematic framework approach was applied for the qualitative analysis.

Results

The TB patient admission rates in Zhenjiang and Hanzhong were 54.8 and 55.9 %, respectively. Qualitative analyses revealed that financial incentives, misunderstanding of infectious disease control and failure of health insurance regulations were the key factors associated with the admission rates and medical costs. Quantitative analyses found differences in hospitalization rate existed among patients with different health insurance and patients from different counties. Average medical costs for TB inpatients in Jurong and Zhenba were 7,215 CNY and 4,644 CNY, which was higher than the 5,500 CNY and 3,800 CNY limits set by the New Rural Cooperative Medical System. No differences in medical cost or length of stay were found between patients with and without comorbidities in county-level hospitals.

Conclusions

TB patient admission rates and inpatient service costs were relatively high. Studies of related factors indicated that a package of interventions, including health education programs, reform of health insurance regulations and improvement of TB treatment guidelines, are urgently required to ensure that TB patients receive appropriate care.

【 授权许可】

   
2016 Hu et al.

【 参考文献 】

• [1]WHO: Global tuberculosis report 2013. World Health Organization, Geneva; 2013.
• [2]Xu B, Dong HJ, Zhao Q, Bogg L: DOTS in China - removing barriers or moving barriers? Health Policy Plan 2006, 21(5):365-72.
• [3]Wang L, Zhang H, Ruan Y, Chin DP, Xia Y, Cheng S, et al.: Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet 2014, 383(9934):2057-64.
• [4]Wei X, Zou G, Walley J, Yin J, Lonnroth K, Uplekar M, et al.: China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data. PLoS One 2014, 9(3):e90596.
• [5]Government of China MOH: Chinese national TB control in the 12th five-year plan. Government of China, Ministry Of Health, Beijing; 2011.
• [6]WHO: What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. World Health Organization, Geneva; 1999.
• [7]WHO: Treatment of tuberculosis: guidelines. World Health Organization, Geneva; 2010.
• [8]Sivaraj R, Umarani S, Parasuraman S, Muralidhar P: Revised National Tuberculosis Control Program regimens with and without directly observed treatment, short-course: a comparative study of therapeutic cure rate and adverse reactions. Perspect Clin Res 2014, 5(1):16-9.
• [9]Garcia-Garcia Mde L, Ponce-De-Leon A, Garcia-Sancho MC, Ferreyra-Reyes L, Palacios-Martinez M, Fuentes J, et al.: Tuberculosis-related deaths within a well-functioning DOTS control program. Emerg Infect Dis 2002, 8(11):1327-33.
• [10]Mo H: National TB control Program (NTP) Guidelines in China. Ministry of Health, Beijing, China; 2008.
• [11]Du J, Emilio D, Pang Y, Ma Y, Mi F, Liu Y, et al.: Tuberculosis hospitalization fees and Bed utilization in China from 1999 to 2009: the results of a national survey of tuberculosis specialized hospitals. PLoS One 2015, 10(10):e0139901.
• [12]Liu X j ZP, Cheng Y f, Zhang P, Yuan F h: Analysis on status of medical cost for tuberculosis patient in reimburse insurance of NRCMCS in Yichang city. J Trop Med 2013, 13(4):516-8.
• [13]Zou G, King R, Walley J, Yin J, Sun Q, Wei X: Barriers to hospital and tuberculosis programme collaboration in China: context matters. Glob Health Action 2015, 8:27067.
• [14]Nutini S, Fiorenti F, Codecasa LR, Casali L, Besozzi G, Di Pisa G, et al.: Hospital admission policy for tuberculosis in pulmonary centres in Italy: a national survey. AIPO Tuberculosis Study Group. Italian Association of Hospital Pulmonologists. Int J Tuberc Lung Dis 1999, 3(11):985-91.
• [15]Pichenda K, Nakamura K, Morita A, Kizuki M, Seino K, Takano T: Non-hospital DOT and early diagnosis of tuberculosis reduce costs while achieving treatment success. Int J Tuberc Lung Dis 2012, 16(6):828-34.
• [16]Gillini L, Davtyan K, Davtyan H, Hayrapetyan A, Khachatryan S, Centis R, et al.: TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia. J Infect Dev Ctries 2013, 7(3):289-92.
• [17]Thierfelder C, Makowiecka K, Vinichenko T, Aye R, Edwards P, Wyss K: Management of pulmonary tuberculosis in Tajikistan: which factors determine hospitalization. Trop Med Int Health 2008, 13(11):1364-71.
• [18]Karasulu AL, Altin S, Dalar L, Sokucu SN, Ozkan P: Can hospitalization provide better compliance in smear positive tuberculosis patients? Tuberk Toraks 2009, 57(3):277-81.
• [19]Long Q, Smith H, Zhang T, Tang S, Garner P: Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health 2011, 11:393. BioMed Central Full Text
• [20]Liu Q, Smith H, Wang Y, Tang S, Wang Q, Garner P: Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: a descriptive study. Trop Med Int Health 2010, 15(1):26-32.
• [21]Tang S, Squire SB: What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective. Health Policy 2005, 72(1):93-104.
• [22]Pan HQ, Bele S, Feng Y, Qiu SS, Lu JQ, Tang SW, et al.: Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China. Int J Tuberc Lung Dis 2013, 17(12):1575-80.
• [23]MOH GoC. National TB control Program (NTP) Guideline in China. Beijng, China; 2008.
• [24]Wei X, Zou G, Yin J, Walley J, Zhang X, Li R, et al.: Effective reimbursement rates of the rural health insurance among uncomplicated tuberculosis patients in China. Trop Med Int Health 2015, 20(3):304-11.
• [25]Wei X, Zou G, Yin J, Walley J, Sun Q: Comparing patient care seeking pathways in three models of hospital and TB programme collaboration in China. BMC Infect Dis 2013, 13:93. BioMed Central Full Text
• [26]Liu X, Thomson R, Gong Y, Zhao F, Squire SB, Tolhurst R, et al.: How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives. Trop Med Int Health 2007, 12(12):1464-71.
• [27]Yip WC, Hsiao W, Meng Q, Chen W, Sun X: Realignment of incentives for health-care providers in China. Lancet 2010, 375(9720):1120-30.
• [28]Liu Y: China’s public health-care system: facing the challenges. Bull World Health Organ 2004, 82(7):532-8.
• [29]Sleigh AC: Health-system reforms to control tuberculosis in China. Lancet 2007, 369(9562):626-7.
• [30]L Z: Dilemma and future: the way of public hospital reform in China. Science Press, Beijing; 2011.
• [31]Yip W, Hsiao W: China’s health care reform: a tentative assessment. China Econ Rev 2009, 20(4):613-9.
• [32]Lapadula G, Zanini F, Codecasa L, Franzetti F, Ferrarese M, Carugati M, et al.: Influence of hospitalization upon diagnosis on the risk of tuberculosis clustering. Mediterr J Hematol Infect Dis 2013, 5(1):e2013071.
• [33]Andrews RH, Devadatta S, Fox W, Radhakrishna S, Ramakrishnan CV, Velu S: Prevalence of tuberculosis among close family contacts of tuberculous patients in South India, and influence of segregation of the patient on early attack rate. Bull World Health Organ 1960, 23:463-510.
• [34]WHO: WHO policy on TB infection control in health-care facilities, congregate settings and households. World Health Organization, Geneva; 2009.
• [35]Wang Wei WM, Du D: Investigation and analysis of hospitalization of TB patients in Quzhou. Chi J Prev Med 2009, 10(2):93-4.